ResearcherXinxiang Central HospitalNo recent work listed

Qi Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-3148-7745; OpenAlex author ID A5101690126. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 1

Papers, trials and grants by year

2021: 2 papers

Papers 2

Thioredoxin-interacting protein is a favored target of miR-125b, promoting metastasis and progression of pancreatic cancer via the HIF1α pathway. Last author DOI 10.1002/jbt.22782 ↗
miR-125b enhances metastasis and progression of cancer via the TXNIP and HIF1α pathway in pancreatic cancer. Last author DOI 10.3233/cbm-203112 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pengli Wang · 2 shared papers, 2021 · strength 0.38
- Paper Thioredoxin-interacting protein is a favored target of miR-125b, promoting metastasis and progression of pancreatic can… DOI 10.1002/jbt.22782 ↗
- Paper miR-125b enhances metastasis and progression of cancer via the TXNIP and HIF1α pathway in pancreatic cancer. DOI 10.3233/cbm-203112 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.